A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection

NCT07367529 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

465

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Lung Cancer

Interventions

DRUG: TQB6411 for Injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.